The U.S. Centers for Disease Control and Prevention has accepted recommendations made by a panel of vaccine experts in April, ...

The new RSV recommendation calls for a single dose of vaccine for adults age 50 to 59 years who are at increased risk of ...

Vaccinating children well in advance allows time for the vaccines to provide the necessary protection before they are exposed ...

MEDICAID CUTS STALL MEGABILL — House Republicans failed to secure enough votes as of Thursday morning for their massive ...

Health Secretary Robert F. Kennedy Jr. endorsed the expanded use of RSV vaccines for people 50 through 59 years old who are ...

GSK is currently the market leader in the meningococcal vaccine market, racking up sales of £1.26 billion (almost $1.6 billion) last year across the Bexsero and Menveo brands, but is having to ...

The Centers for Disease Control and Prevention (CDC) has adopted new vaccine recommendations that expand protection for respiratory syncytial virus (RSV) and meningococcal disease, backing products ...

Armed with new data, GSK is preparing to file for approval of its new-generation meningitis vaccine, as it tries to maintain its leadership in the category against a challenge from Pfizer ...

Good morning, it’s the third of July. This newsletter will be off tomorrow for the holiday and — surprise — all of next week.

Flu B is on the rise among kids and teens. Learn why this year’s flu season is different, who gets free shots, and how to ...